Cipla promoters plan to sell 2.53% stake
Mint. The promoters are offering to sell up to 20.45 million shares, with a total deal value estimated to be around ₹2,637 crore ($316 million).
The shares are being offered within a price range of ₹1,289.50 to ₹1,357.35 per share, representing a discount of 0-5% compared to Cipla's closing share price of ₹1,357.35 on the NSE on 14 May 2024. Kotak Securities Ltd is managing the sale process.
Cipla spokespersons did not respond to emails seeking comment. Also read: Cipla's Q4 profit jumps 79%, but fails to cheer Street Currently, the promoters hold a combined stake of 4.26% in Cipla, with Shirin Hamied, Samina Hamied, Rumana Hamied and Okasa Pharma holding 0.79%, 2.22%, 1.23%, and 0.02%, respectively.
This move comes amidst a strong year for Cipla's stock price, which has surged by 45% so far in 2024, significantly outperforming the benchmark Nifty 50 index that has gained 21.3%. Also read: Family rift clouds $7 bn sale of Cipla Interestingly, this is not the first time the Cipla promoters have explored stake dilution.
Read more on livemint.com
